CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 2008; 58:9-31
doi: 10.3322/CA.2007.0011
© 2008 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow All Versions of this Article:
CA.2007.0011v1
58/1/9    most recent
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ward, E.
Right arrow Articles by Jemal, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ward, E.
Right arrow Articles by Jemal, A.

Association of Insurance with Cancer Care Utilization and Outcomes

Elizabeth Ward, PhD, Michael Halpern, MD, PhD, Nicole Schrag, MSPH, Vilma Cokkinides, PhD, MSPH, Carol DeSantis, MPH, Priti Bandi, MS, Rebecca Siegel, MPH, Andrew Stewart, MA and Ahmedin Jemal, DVM, PhD

Dr. Ward is Managing Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Halpern is Strategic Director, Health Services Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Schrag is Epidemiologist, Health Services Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Cokkinides is Strategic Director, Cancer Risk Factors and Screening, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. DeSantis is Epidemiologist, Cancer Surveillance, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Bandi is Epidemiologist, Cancer Risk Factors and Screening, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Siegel is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Mr. Stewart is Senior Manager, National Cancer Data Base, Commission on Cancer, American College of Surgeons, Chicago, IL.
Dr. Jemal is Strategic Director, Cancer Surveillance, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.

Published online through CA First Look at http://CAonline.AmCancerSoc.org.

Advances in the prevention, early detection, and treatment of cancer have resulted in an almost 14% decrease in the death rates from all cancers combined from 1991 to 2004 in the overall US population, with remarkable declines in mortality for the top 3 causes of cancer death in men (lung, colorectal, and prostate cancer) and 2 of the top 3 cancers in women (breast and colorectal cancer). However, not all segments of the population have benefited equally from this progress, and evidence suggests that some of these differences are related to lack of access to health care. Lack of adequate health insurance appears to be a critical barrier to receipt of appropriate health care services. This article provides an overview of systems of health insurance in the United States, demographic and socioeconomic characteristics associated with health insurance coverage, and economic burdens related to health care among individuals and families. This article also presents data on the association between health insurance status and screening, stage at diagnosis, and survival for breast and colorectal cancer based on analyses of the National Health Interview Survey and the National Cancer Data Base. Although this article focuses on associations between health insurance and cancer care utilization and outcomes, it is important to recognize that barriers to receipt of optimal cancer care are complex and involve patient-level, provider, and health system factors. Evidence presented in this paper suggests that addressing insurance and cost-related barriers to care is a critical component of efforts to ensure that all Americans are able to share in the progress that can be achieved by access to high-quality cancer prevention, early detection, and treatment services.




This article has been cited by other articles:


Home page
 JCOHome page
J. L. Warren, A. B. Mariotto, A. Meekins, M. Topor, and M. L. Brown
Current and Future Utilization of Services From Medical Oncologists
J. Clin. Oncol., July 1, 2008; 26(19): 3242 - 3247.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
Y.-C. T. Shih and M. T. Halpern
Economic Evaluations of Medical Care Interventions for Cancer Patients: How, Why, and What Does it Mean?
CA Cancer J Clin, July 1, 2008; 58(4): 231 - 244.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
R. A. Smith, V. Cokkinides, and O. W. Brawley
Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues
CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
E. Huerta
Editorial
CA Cancer J Clin, January 1, 2008; 58(1): 7 - 8.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by American Cancer Society.